BMC Med:循环Nrg4水平与代谢综合征有什么关系?

2016-10-27 MedSci MedSci原创

神经调节蛋白4(Nrg4)是一种分泌的脂肪细胞因子,在调节能量代谢系统和肥胖相关疾病的发展中发挥着重要的作用。然而循环NRG4和代谢综合征(MetS)风险之间的联系还是未知的。我们测量了1212肥胖的成年人(40岁以上)的血清Nrg4,这些参与者的腰围大于90厘米(男性)或80厘米(女性)。与健康对照组比较,代谢综合征者有较低的循环Nrg4水平(P < 0.01)。与高循环Nrg4水平的参与

神经调节蛋白4(Nrg4)是一种分泌的脂肪细胞因子,在调节能量代谢系统和肥胖相关疾病的发展中发挥着重要的作用。然而循环NRG4和代谢综合征(MetS)风险之间的联系还是未知的。

我们测量了1212肥胖的成年人(40岁以上)的血清Nrg4,这些参与者的腰围大于90厘米(男性)或80厘米(女性)。

与健康对照组比较,代谢综合征者有较低的循环Nrg4水平(P < 0.01)。与高循环Nrg4水平的参与者比较,低水平的循环Nrg4参与者的代谢综合征患病率较高(67.3 % vs. 57.4 %, P < 0.05)。同样的,低水平的循环Nrg4受试者的空腹血糖和血压升高的患病率较高,但有与甘油三酯升高和HDL-C降低无关。多变量Logistic回归分析显示,增加血清Nrg4与显著降低MetS的风险相关(OR: 0.603; 95 % CI, 0.439–0.828; P = 0.002),校正年龄、性别、吸烟、饮酒、体力活动、体重指数、收缩压、空腹血糖、甘油三酯、高密度脂蛋白胆固醇、胰岛素抵抗指数和身体脂肪量;然而,血清Nrg4与代谢综合征各成分之间没有相关性。

这些结果表明,循环Nrg4浓度与肥胖成人代谢综合征的风险成反比,提示循环Nrg4浓度可能是代谢综合征发展的保护性因素。

原始出处:


Chengfu Cai,et al.Association of circulating neuregulin 4 with metabolic syndrome in obese adults: a cross-sectional study.BMC Medicine.Published: 24 October 2016

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1974702, encodeId=7d1f19e470226, content=<a href='/topic/show?id=f145355379' target=_blank style='color:#2F92EE;'>#BMC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3553, encryptionId=f145355379, topicName=BMC)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/101173734/363C99735735B7F4CB11D5F78F580525/100, createdBy=aab22500211, createdName=ms3025846204744509, createdTime=Tue Mar 07 22:06:00 CST 2017, time=2017-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=154886, encodeId=389e154886c2, content=谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fe261399236, createdName=xyfg98, createdTime=Thu Nov 10 21:53:02 CST 2016, time=2016-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=153312, encodeId=8f10153312bb, content=学习了,好东东,值得分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJUxfqEBLTrFZvMCToegPxv4CovnkibcroaO2d41HROFgTh9Acnhia4m6BiaRwLMpm8tC9yticL9WQ2lQ/132, createdBy=428e1975226, createdName=小靖儿, createdTime=Fri Nov 04 10:15:19 CST 2016, time=2016-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1430713, encodeId=fa921430e139e, content=<a href='/topic/show?id=f9b9e9124a8' target=_blank style='color:#2F92EE;'>#综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79124, encryptionId=f9b9e9124a8, topicName=综合征)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Sat Oct 29 08:06:00 CST 2016, time=2016-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1607176, encodeId=ab6c160e17639, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sat Oct 29 08:06:00 CST 2016, time=2016-10-29, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1974702, encodeId=7d1f19e470226, content=<a href='/topic/show?id=f145355379' target=_blank style='color:#2F92EE;'>#BMC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3553, encryptionId=f145355379, topicName=BMC)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/101173734/363C99735735B7F4CB11D5F78F580525/100, createdBy=aab22500211, createdName=ms3025846204744509, createdTime=Tue Mar 07 22:06:00 CST 2017, time=2017-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=154886, encodeId=389e154886c2, content=谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fe261399236, createdName=xyfg98, createdTime=Thu Nov 10 21:53:02 CST 2016, time=2016-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=153312, encodeId=8f10153312bb, content=学习了,好东东,值得分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJUxfqEBLTrFZvMCToegPxv4CovnkibcroaO2d41HROFgTh9Acnhia4m6BiaRwLMpm8tC9yticL9WQ2lQ/132, createdBy=428e1975226, createdName=小靖儿, createdTime=Fri Nov 04 10:15:19 CST 2016, time=2016-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1430713, encodeId=fa921430e139e, content=<a href='/topic/show?id=f9b9e9124a8' target=_blank style='color:#2F92EE;'>#综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79124, encryptionId=f9b9e9124a8, topicName=综合征)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Sat Oct 29 08:06:00 CST 2016, time=2016-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1607176, encodeId=ab6c160e17639, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sat Oct 29 08:06:00 CST 2016, time=2016-10-29, status=1, ipAttribution=)]
    2016-11-10 xyfg98

    谢谢分享!

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1974702, encodeId=7d1f19e470226, content=<a href='/topic/show?id=f145355379' target=_blank style='color:#2F92EE;'>#BMC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3553, encryptionId=f145355379, topicName=BMC)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/101173734/363C99735735B7F4CB11D5F78F580525/100, createdBy=aab22500211, createdName=ms3025846204744509, createdTime=Tue Mar 07 22:06:00 CST 2017, time=2017-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=154886, encodeId=389e154886c2, content=谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fe261399236, createdName=xyfg98, createdTime=Thu Nov 10 21:53:02 CST 2016, time=2016-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=153312, encodeId=8f10153312bb, content=学习了,好东东,值得分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJUxfqEBLTrFZvMCToegPxv4CovnkibcroaO2d41HROFgTh9Acnhia4m6BiaRwLMpm8tC9yticL9WQ2lQ/132, createdBy=428e1975226, createdName=小靖儿, createdTime=Fri Nov 04 10:15:19 CST 2016, time=2016-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1430713, encodeId=fa921430e139e, content=<a href='/topic/show?id=f9b9e9124a8' target=_blank style='color:#2F92EE;'>#综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79124, encryptionId=f9b9e9124a8, topicName=综合征)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Sat Oct 29 08:06:00 CST 2016, time=2016-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1607176, encodeId=ab6c160e17639, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sat Oct 29 08:06:00 CST 2016, time=2016-10-29, status=1, ipAttribution=)]
    2016-11-04 小靖儿

    学习了,好东东,值得分享

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1974702, encodeId=7d1f19e470226, content=<a href='/topic/show?id=f145355379' target=_blank style='color:#2F92EE;'>#BMC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3553, encryptionId=f145355379, topicName=BMC)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/101173734/363C99735735B7F4CB11D5F78F580525/100, createdBy=aab22500211, createdName=ms3025846204744509, createdTime=Tue Mar 07 22:06:00 CST 2017, time=2017-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=154886, encodeId=389e154886c2, content=谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fe261399236, createdName=xyfg98, createdTime=Thu Nov 10 21:53:02 CST 2016, time=2016-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=153312, encodeId=8f10153312bb, content=学习了,好东东,值得分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJUxfqEBLTrFZvMCToegPxv4CovnkibcroaO2d41HROFgTh9Acnhia4m6BiaRwLMpm8tC9yticL9WQ2lQ/132, createdBy=428e1975226, createdName=小靖儿, createdTime=Fri Nov 04 10:15:19 CST 2016, time=2016-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1430713, encodeId=fa921430e139e, content=<a href='/topic/show?id=f9b9e9124a8' target=_blank style='color:#2F92EE;'>#综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79124, encryptionId=f9b9e9124a8, topicName=综合征)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Sat Oct 29 08:06:00 CST 2016, time=2016-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1607176, encodeId=ab6c160e17639, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sat Oct 29 08:06:00 CST 2016, time=2016-10-29, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1974702, encodeId=7d1f19e470226, content=<a href='/topic/show?id=f145355379' target=_blank style='color:#2F92EE;'>#BMC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3553, encryptionId=f145355379, topicName=BMC)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/101173734/363C99735735B7F4CB11D5F78F580525/100, createdBy=aab22500211, createdName=ms3025846204744509, createdTime=Tue Mar 07 22:06:00 CST 2017, time=2017-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=154886, encodeId=389e154886c2, content=谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fe261399236, createdName=xyfg98, createdTime=Thu Nov 10 21:53:02 CST 2016, time=2016-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=153312, encodeId=8f10153312bb, content=学习了,好东东,值得分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJUxfqEBLTrFZvMCToegPxv4CovnkibcroaO2d41HROFgTh9Acnhia4m6BiaRwLMpm8tC9yticL9WQ2lQ/132, createdBy=428e1975226, createdName=小靖儿, createdTime=Fri Nov 04 10:15:19 CST 2016, time=2016-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1430713, encodeId=fa921430e139e, content=<a href='/topic/show?id=f9b9e9124a8' target=_blank style='color:#2F92EE;'>#综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79124, encryptionId=f9b9e9124a8, topicName=综合征)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Sat Oct 29 08:06:00 CST 2016, time=2016-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1607176, encodeId=ab6c160e17639, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sat Oct 29 08:06:00 CST 2016, time=2016-10-29, status=1, ipAttribution=)]

相关资讯

国家经济水平影响胆固醇升高率

  美国学者的一项研究表明,在伴有高脂血症病史的患者中,胆固醇升高患病率的全球变异与国家水平的经济发展和保健系统指数相关。论文于2012年4月9日在线发表于《循环》(Circulation)杂志。   血清胆固醇升高引发了相当高比例的心血管疾病。对国家水平的经济和保健系统因素与胆固醇升高的相关性加以了解有助于明确心血管预防项目的优先性。此项研究共纳入来自36个国家的53570例门诊患者,并利用分

血液检查可用于BRCA1,2突变携带者的检测

简单的血液检查将有助于诊断出携带有BRCA1和2突变的遗传性乳腺癌和卵巢癌。 巴勒斯坦耶路撒冷Hadassah 大学医院Sharett 肿瘤研究所住院部主任Asher Salmon博士报告称,对于疑似携带有BRCA1/2突变的女性,采用这种检查便可避免使用价格高昂的基因序列检测,也便于快速作出诊疗决策。这种检查只需6天就能获得结果,而目前采用的方法需要6周。 虽然这种新的血液检查仍处于

半数心脏病发作在一个月前就出现先兆

据英国《每日邮报》近日报道,美国一项新研究发现,在中年男性患者中,半数心脏病发作(如心梗等)病例在一个月之前就已出现先兆。 新研究中,美国洛杉矶市希达西奈心脏研究所的科学家对俄勒冈州波特兰市2002~2012年发生的825例心脏骤停病例进行了分析,这些病例均为男性,年龄在35~65岁之间。结果发现,超过半数患者一个月前出现的症状可预测其心脏病发作危险,56%的人出现胸痛、13%的人出现气

Eur Heart J:研究支持心血管疾病的炎症假说

2014年3月的 Eur Heart J 发表一项研究显示,白细胞介素-6(IL - 6)、IL-18、基质金属蛋白酶-9(MMP-9)、可溶性CD40配体(sCD40L)和肿瘤坏死因子-α(TNF-α)与冠心病风险独立相关。这一发现进一步支持了血管疾病的炎症假说。 研究背景   炎症过程可能在血管疾病的发病中发挥重要作用,血液循环中炎症标志物与冠心病(CHD)的相关性引起了大

Circulation:疤痕相关室性心动过速(VT)改良新终点

  研究显示,对于疤痕相关的室性心动过速(VT),明确局部异常心室活动(LAVA)并消除LAVA 是安全可行的,患者存活率更高,且可避免VT复发。该研究2012年4月4日在线发表于《循环》(Circulation)杂志。   导管消融治疗VT有效,而且在需要经常除颤的患者中特别有用,对于不能描记的或血流动力学不耐受的VT,有各种不同的基质改良技术。非诱导性是最常被使用的VT终点,但其有